GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Market Closed 01-30 16:00:00 EST

51.60

+0.94

+1.86%

盘后51.75

+0.15+0.29%

19:59 EST

High51.69	Low51.06	Vol5.49M
Open51.14	D1 Closing50.66	Amplitude1.25%
Mkt Cap105.16B	Tradable Cap100.46B	Total Shares2.04B
T/O282.21M	T/O Rate0.28%	Tradable Shares1.95B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":51.6,"timestamp":1769806800000,"preClose":50.66,"halted":0,"volume":5489868,"hourTrading":{"tag":"盘后","latestPrice":51.7494,"preClose":51.6,"latestTime":"19:59 EST","volume":15124,"amount":780589.0381,"timestamp":1769821172823,"change":0.1494,"changeRate":0.002895,"amplitude":0.002895},"delay":0,"changeRate":0.018555073035925875,"floatShares":1946891708,"shares":2037944753,"eps":3.572046,"marketStatus":"Market Closed","change":0.94,"latestTime":"01-30 16:00:00 EST","open":51.14,"high":51.69,"low":51.055,"amount":282213636.67236,"amplitude":0.012535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.572046,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770022800000},"marketStatusCode":7,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":50.66,"dividendRate":0.032862,"preHourTrading":{"tag":"盘前","latestPrice":51.12,"preClose":50.66,"latestTime":"09:29 EST","volume":33738,"amount":1722765.2821139998,"timestamp":1769783399081,"change":0.46,"changeRate":0.00908,"amplitude":0.011844},"postHourTrading":{"tag":"盘后","latestPrice":51.7494,"preClose":51.6,"latestTime":"19:59 EST","volume":15124,"amount":780589.0381,"timestamp":1769821172823,"change":0.1494,"changeRate":0.002895,"amplitude":0.002895},"volumeRatio":1.03408898220404,"impliedVol":0.3195,"impliedVolPercentile":0.8008},"requestUrl":"/m/hq/s/GSK","defaultTab":"news","newsList":[{"id":"1175822063","title":"Earning Preview: GlaxoSmithKline PLC Q4 revenue is expected to increase by 17.57%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1175822063","media":"Earnings Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/1175822063?lang=en_us&edition=fundamental","pubTime":"2026-01-28 11:43","pubTimestamp":1769571820,"startTime":"0","endTime":"0","summary":"AbstractGlaxoSmithKline PLC will report quarterly results on February 04, 2026 Pre-Market; this preview consolidates financial data and forecasts through January 28, 2026, highlighting consensus...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: GlaxoSmithKline PLC Q4 revenue is expected to increase by 17.57%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2607028667","title":"GSK Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2607028667","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607028667?lang=en_us&edition=fundamental","pubTime":"2026-01-31 01:07","pubTimestamp":1769792820,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares rose 1.32% to GBP18.77 Friday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index  rising 0.51% to 10,223.54.GSK PLC closed 8.81% short of its 52-week high of GBP20.58, which the company achieved on December 19th.Trading volume totaled 8.1 million, compared to the 50-day average of 8.0 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2607040287","title":"GSK Advances Shigella Vaccine Program With Completed Phase 2 Trial in African Infants","url":"https://stock-news.laohu8.com/highlight/detail?id=2607040287","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607040287?lang=en_us&edition=fundamental","pubTime":"2026-01-31 00:30","pubTimestamp":1769790651,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study OverviewGlaxoSmithKline (GSK) is running a Phase 2 trial titled “...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-shigella-vaccine-program-with-completed-phase-2-trial-in-african-infants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-shigella-vaccine-program-with-completed-phase-2-trial-in-african-infants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4588","GSK.UK","BK4585","BK4007","LU1829250122.USD","BK4532"],"gpt_icon":0},{"id":"2607040402","title":"GSK’s Long-Term Nucala Study in EGPA Nears the Finish Line: What Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2607040402","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607040402?lang=en_us&edition=fundamental","pubTime":"2026-01-31 00:30","pubTimestamp":1769790612,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study OverviewGlaxoSmithKline (GSK) is running an observational study c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-long-term-nucala-study-in-egpa-nears-the-finish-line-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-long-term-nucala-study-in-egpa-nears-the-finish-line-what-investors-should-know?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4532","GSK","LU1829250122.USD","ISBC","BK4585","GSK.UK","BK4007","BK4588"],"gpt_icon":0},{"id":"2607801702","title":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2607801702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607801702?lang=en_us&edition=fundamental","pubTime":"2026-01-30 20:07","pubTimestamp":1769774827,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat loomsChanges dateline, adds Eli Lilly details in paragraph 11. Jan 30  - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.Although enforcement is delayed for companies investing in U.S. manufacturing, the policy has already prompted fast-tracked projects, price cuts and direct-to-consumer sales.Pfizer and AstraZeneca secured multi-year tariff exemptions through pricing deals and commitments to the new TrumpRx.gov platform. Eli Lilly, Johnson & Johnson and Merck have pledged billions to expand U.S. operations to avoid penalties.Here's what drugmakers are doing to mitigate supply-chain risks and reassure investors:Pfizer PFE.N Pfizer reached a deal with President Donald Trump on September 30 to invest $70 billion in research and development and domestic manufacturing, and received a three-year grac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nL4N3YV11K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU0648001328.SGD","LU1069344957.HKD","LU2430703251.USD","LU1093756325.SGD","LU0545039389.USD","LU1019634622.SGD","LU0353189680.USD","SG9999015358.SGD","LU0882574055.USD","LU2461242641.AUD","LU2264538146.SGD","LU1934455863.HKD","GB00BDT5M118.USD","LU2750360997.AUD","IE00B4JS1V06.HKD","LU0964806797.USD","LU2087625088.SGD","LU1894683264.USD","LU0827474353.SGD","LU0316494557.USD","LU2091194634.USD","LU0069063385.USD","SG9999017495.SGD","IE00BZ1G4Q59.USD","LU0158827781.USD","LU0234570918.USD","LU0557290698.USD","SG9999015952.SGD","SG9999011175.SGD","BK4504","LU2125154778.USD","LU1506573853.SGD","LU0321505868.SGD","LU0957799991.USD","LU0109394709.USD","LU0158827948.USD","LU2293690249.USD","LU0130517989.USD","IE0002270589.USD","IE00BWXC8680.SGD","LU0496365809.HKD","LU0306807586.USD","IE00B4R5TH58.HKD","LU1551013342.USD","LU0114720955.EUR","LU2063271972.USD","LU2746668461.USD","SG9999014914.USD","LU0354030511.USD","LU1778281490.HKD","IE00BK4W5L77.USD","IE00BGHQF631.EUR","LU1481599808.USD","LU2106854487.HKD","IE000M9KFDE8.USD","LU0211328371.USD","LU2462157665.USD","LU1116320737.USD","LU1267930227.SGD","LU1941712348.USD","LU0960981461.USD","BK7511","LU2237443895.HKD","CSL.AU","LU1035775433.USD","SG9999013999.USD","LU0949170772.SGD","LU0965509283.SGD","LU1003077747.HKD","LU0321505439.SGD","03165","LU1983299246.USD","LU1066051225.USD","IE00BVYPNV92.GBP","SG9999014898.SGD","LU0345770993.USD","LU0210536198.USD","LU0672654240.SGD","LU0052756011.USD","IE00BVYPNW00.USD","LU0963555726.SGD","LU2129689431.USD","BIIB","LU0708995401.HKD","SG9999014906.USD","LU0889565080.SGD","LU0985481810.HKD","BK4139","LU1232071149.USD","LU0310800379.SGD","LU0823416689.USD","LU1059921491.USD","LU0689472784.USD","SG9999003800.SGD","LU1487256676.USD","BK4550","AZN","LU0266013472.USD","IE0034235303.USD","LU2242652126.USD","GILD","IE00B7SZLL34.SGD","LU0310799852.SGD","LU1084165304.USD","LU1814569148.SGD","LU0289739343.SGD","IE00BN29S564.USD","LU0225283273.USD","LU1104425308.USD","SG9999001176.SGD","LU1585245621.USD","BK4532","LU0203201768.USD","LU0882574139.USD","LU0575583348.USD","LU0949170426.SGD","LU1280957306.USD","LU1301847155.USD","IE00B1XK9C88.USD","LU0823434740.USD","LU1201861249.SGD","LU1868836757.USD","LU2237443549.SGD","LU2471134952.CNY","LU0320765059.SGD","IE00BFSS8Q28.SGD","LU1015430645.USD","LU0861579265.USD","LU1718418525.SGD","LU1880407132.USD","IE00B3T34201.USD","LU2133065610.SGD","LU1078025761.USD","LU0094547139.USD","LU2211815571.USD","LU0211326755.USD","IE00BLSP4239.USD","LU0466842654.USD","LLY","SG9999015986.USD","LU2237443978.SGD","LU2468319806.SGD","LU2471134796.USD","LU1914381329.SGD","IE00BBT3K403.USD","IE00B42XCP33.USD","LU2236285917.USD","LU0203347892.USD","LU0354030438.USD","LU1019632923.USD","LU0661504455.SGD","IE00BJJMRY28.SGD","LU1066051811.HKD","LU2491050154.USD","LU0006306889.USD","LU2111349929.HKD","LU0029864427.USD","LU2746668974.SGD","LU1244550494.USD","BK4566","LU1989772840.SGD","BK7501","SG9999014575.USD","LU1064927863.SGD","LU0784385170.HKD","LU0256863902.USD","LU1127390331.HKD","LU1868836914.USD","LU1119994496.HKD","LU1699723380.USD","LU2129689514.USD","LU0640478417.SGD","LU0868494617.USD","SG9999015341.SGD","LU0823434583.USD","LU2129689605.HKD","LU2237438978.USD","IE00B7KXQ091.USD","LU2750360641.GBP","LU0471298694.HKD","SG9999014567.USD","LU0997586432.USD","LU1720051017.SGD","LU0943347566.SGD","SGXZ99366536.SGD","LU0070217475.USD","BK4588","LU0171293334.USD","LU0417517546.SGD","LU1064131342.USD","LU2023250843.SGD","BK4578","LU0047473722.SGD","LU0980610538.SGD","BK4533","LU2237443465.HKD","LU0345777659.USD","LU2108987350.USD","IE00BKPKM643.USD","LU2592432038.USD","LU0289739699.SGD","LU0345777147.USD","LU0211326839.USD","LU1291159041.SGD","BK4599","LU0234572021.USD","LU1674673428.USD","LU2417539215.USD","LU0499090636.EUR","BK7067","IE00B19Z3B42.SGD","IE0004445239.USD","IE00BK4W5M84.HKD","LU0823399737.USD","LU0553294199.USD","LU1196500208.SGD","LU2168563687.JPY","LU2552382058.USD","LU1481600234.SGD","LU1894683348.USD","LU0070302665.USD","LU0511384066.AUD","LU0456855351.SGD","ABBV","LU1267930730.SGD","LU0265550946.USD","LU0345770308.USD","LU0972486137.USD","LU2361044865.SGD","LU0920783379.SGD","LU2552382132.HKD","LU1868836591.USD","IE00BFTCPJ56.SGD","LU0170899867.USD","LU1057294990.SGD","LU2360106947.USD","LU1571399168.USD","IE00B19Z3581.USD","LU2271345857.HKD","LU2360032135.SGD","LU2361044949.HKD","LU1244550577.SGD","LU0320765992.SGD","LU0795875169.SGD","LU0203345920.USD","LU0238689110.USD","LU0784383803.USD","BK4592","SG9999002232.USD","LU0965509101.SGD","LU0011850046.USD","IE00B19Z9Z06.USD","LU0128525689.USD","LU0471298777.SGD","LU2293690082.USD","LU1732800096.USD","LU0058720904.USD","LU1069347547.HKD","LU0477156953.USD","LU0708994859.HKD","IE00BLSP4452.SGD","LU0784384876.USD","LU0061475181.USD","LU0124676726.USD","LU1267930573.SGD","LU2237443622.USD","LU0795875086.SGD","LU1162221912.USD","LU2347655156.SGD","LU0786609619.USD","LU2602419157.SGD","BK4585","LU2023251221.USD","LU2361045086.USD","LU0097036916.USD","IE0034235188.USD","BK5011","LU1323610961.USD","SG9999018857.SGD","LU0225284248.USD","LU2456880835.USD","LU1551013425.SGD","LU1623119135.USD","LU1974910355.USD","SGXZ31699556.SGD","LU2471134879.HKD","LU1868837300.USD","LU0969580561.USD","LU0784385840.USD","LU1003076772.USD","LU1366192091.USD","SG9999015945.SGD","LU1221951046.USD","LU1430594728.SGD","LU2089283258.USD","IE00BFSS7M15.SGD","LU0047473722.EUR","LU0106261372.USD","SGXZ51526630.SGD","IE00BFXG1179.USD","LU0323591593.USD","LU0265550359.USD","IE0004445015.USD","LU1674673691.USD","IE00BJJMRZ35.SGD","LU0057025933.USD","LU0857590862.USD","SG9999014880.SGD","LU0912757837.SGD","LU0320765646.SGD","LU2112291526.USD","04332","SG9999001440.SGD","LU0820561909.HKD","LU0203202063.USD","LU2028103732.USD","LU0353189763.USD","SG9999014559.SGD","LU0320765489.SGD","GSK","LU1267930490.SGD","LU0787776722.HKD","LU0306806265.USD","LU1989772923.USD","BK4568","LU1988902786.USD","LU2552382215.SGD","LU1221951129.SGD","LU2471134523.USD","LU1116320901.HKD","LU2430703178.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU1868837136.USD","LU2357305700.SGD","IE00BJLML261.HKD","LU0472753341.HKD","LU1935042991.SGD","LU2168564149.EUR","LU1074936037.SGD","IE00BJT1NW94.SGD","LU1267930813.SGD","LU0211327993.USD","BK4534","LU2168564495.EUR","IE00B775H168.HKD","LU1051770623.HKD","BK4583","LU0077335932.USD","LU2505996509.AUD","IE00BJJMRX11.SGD","LU2089984988.USD","LU0526926950.USD","LU2087621335.USD","SG9999018865.SGD","LU0130102774.USD","LU2491049909.HKD","LU0757432116.USD","IE00BN8TJ469.HKD","LU1732799900.SGD","LU0976567544.SGD","BK4516","LU1839511570.USD","LU0820561818.USD","LU1153584641.USD","IE00B3PB1722.GBP","LU1061106388.HKD","LU2265009873.SGD","LU0385154629.USD","LU0345769128.USD","LU1066051498.USD","IE0005OL40V9.USD","IE00B894F039.SGD","NVS","LU0098860793.USD","LU1035773651.USD","LU1037948897.HKD","AMGN","BK4007","LU1032466523.USD","LU1934455277.USD","LU0689626769.HKD","LU0109391861.USD","BK4559","LU2430703095.HKD","LU0096364046.USD","LU1261432733.SGD","LU1496350171.SGD","IE00BKVL7J92.USD","LU0985320562.USD","IE00BDGV0183.EUR","LU1548497426.USD","LU2125154935.USD","LU1244550221.USD","LU1883839398.USD","LU2491050071.SGD","SG9999002224.SGD","PFE","SG9999015978.USD","LU0198837287.USD","LU1066053197.SGD","LU2324357040.USD","IE00B2B36J28.USD","LU1153585028.USD","LU1804176565.USD","IE0002141913.USD","LU1496350502.SGD","LU0965509010.AUD","LU1023059063.AUD","RHHBY","LU2896262040.SGD","IE0009355771.USD","LU2279689827.SGD","MRK","LU0079474960.USD","SGXZ81514606.USD","LU0122379950.USD","IE00BKDWB100.SGD","SNY","LU0345769631.USD","LU0432979614.USD","LU1880407215.USD","LU0738911758.USD","LU1941712264.USD","LU0792757196.USD","LU0920840948.USD","LU2089284900.SGD","LU0889566641.SGD","LU2237443382.USD","LU1929549753.HKD","LU1934455194.USD","JNJ","BK7508","LU2023250504.SGD","LU0256863811.USD","LU1720051108.HKD","SG9999014542.SGD","LU0640476718.USD","LU2168564222.USD","LU2168564065.EUR","LU2505996681.GBP","LU2539964713.USD","LU0310800965.SGD","LU2242646821.SGD","LU0211331839.USD","LU1093756168.USD","LU0225771236.USD","LU0289961442.SGD","LU1037948541.HKD","LU1032955483.USD","LU1917777945.USD","LU1989771016.USD","LU1712237335.SGD","LU2114397693.USD","SGXZ57979304.SGD","SG9999001176.USD","BK4581","IE00B19Z9P08.USD","LU0208291251.USD","LU1170363599.USD","LU0965508806.USD","LU0128525929.USD","IE00BSNM7G36.USD","LU0889565916.HKD"],"gpt_icon":1},{"id":"2607187037","title":"Update: European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2607187037","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607187037?lang=en_us&edition=fundamental","pubTime":"2026-01-30 01:26","pubTimestamp":1769707581,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were down late Thursday morning, declining 0.82% to 1,802.03 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor , which rose 1.9%. They were followed by brewing company Anheuser-Busch InBev  and oil and gas company Eni , which were up 1.5% and 1.2% respectively.The decliners from continental Europe were led by software firm SAP  and telecommunications company Nokia , which dropped 17% and 9.3% respectively. They were followed by semiconductor company Sequans Communications  and internet browser company Opera , which lost 8.3% and 4.4% respectively.From the UK and Ireland, the gainers were led by cruise line operator Carnival  and mining company BHP Group , which advanced 7% and 2.1% respectively. They were followed by oil and gas company Shell  and pharmaceutical company GSK , which increased 1.9% and 1.8% respectively.The decliners from the UK and Ireland were ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","GSK","BDRX","BUD","NOK","BK4117","SHEL","BK7507","BK7095","TRIB","BK4139","IE00BMPRXN33.USD","BK4007","NCNA","BK4585","CUK","BK4158","BK4528","MREO","SQNS","GSK.UK","BK4547","EQNR","E","LU0098860793.USD","BK4107","BHP","IE00BMPRXR70.SGD","SAP","BK4020","BHP.AU","BK4532","BK4082","LU0320765646.SGD","AFG","LU0300736492.USD","BK4168","BK4023","BK4142","BK4505","LU0278409577.USD","BK7119","LU1829250122.USD","OPRA","BUD.AU","LU1162221912.USD","BK4613","LU0300736062.USD","LU2236285917.USD"],"gpt_icon":0},{"id":"2607803291","title":"GSK Rallies Thursday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2607803291","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607803291?lang=en_us&edition=fundamental","pubTime":"2026-01-30 01:06","pubTimestamp":1769706360,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of GSK PLC  rallied 1.90% to GBP18.52 Thursday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index  rising 0.17% to 10,171.76.GSK PLC closed 10.00% below its 52-week high of GBP20.58, which the company reached on December 19th.Trading volume totaled 6.3 million, compared to the 50-day average of 8.0 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2607746658","title":"GSK Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2607746658","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607746658?lang=en_us&edition=fundamental","pubTime":"2026-01-29 01:05","pubTimestamp":1769619900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares shed 2.42% to GBP18.18 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index  falling 0.52% to 10,154.43.GSK PLC closed 11.67% below its 52-week high of GBP20.58, which the company reached on December 19th.Trading volume totaled 7.2 million, compared to the 50-day average of 7.9 million.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2606838711","title":"Medicare is about to start negotiating the prices of medications administered by doctors","url":"https://stock-news.laohu8.com/highlight/detail?id=2606838711","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606838711?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:07","pubTimestamp":1769605620,"startTime":"0","endTime":"0","summary":"The 15 drugs selected for negotiation include Eli Lilly's breast-cancer drug Verzenio. CMS Administrator Mehmet Oz said the agency is taking \"strong action\" to address drug costs under Medicare. . The U.S. plans to negotiate the prices of 15 more medications covered by Medicare, including two of Eli Lilly's top-selling drugs - though there were few surprises.The Centers for Medicare and Medicaid Services on Tuesday announced the third round of drugs included in the Medicare Drug Price Negotiation Program.\"CMS is taking strong action to target the most expensive drugs in Medicare, negotiate fair prices, and make sure the system works for patients - not special interests,\" CMS Administrator Mehmet Oz said in a statement.This time, the program includes, for the first time, medicines covered by Part B, which are drugs administered by clinicians in outpatient settings, in addition to those covered by Medicare Part D, which handles medications you can pick up at a pharmacy.The pharmaceutical","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0683600562.USD","LU1069344957.HKD","LU2430703251.USD","LU1093756325.SGD","LU0545039389.USD","IE00BSNM7G36.USD","LU0353189680.USD","LU0882574055.USD","LU2461242641.AUD","LU2264538146.SGD","LU1934455863.HKD","GB00BDT5M118.USD","LU2750360997.AUD","IE00B4JS1V06.HKD","LU2087625088.SGD","LU1894683264.USD","LU0316494557.USD","LU0069063385.USD","SG9999017495.SGD","IE00BZ1G4Q59.USD","LU0158827781.USD","LU0234570918.USD","SG9999015952.SGD","SG9999011175.SGD","BK4504","LU2125154778.USD","LU1506573853.SGD","LU0321505868.SGD","LU0109394709.USD","LU0158827948.USD","IE0002270589.USD","IE00BWXC8680.SGD","LU0306807586.USD","IE00B4R5TH58.HKD","LU1551013342.USD","LU0114720955.EUR","LU2063271972.USD","LU2746668461.USD","SG9999014914.USD","LU0354030511.USD","LU1778281490.HKD","IE00BK4W5L77.USD","LU2106854487.HKD","IE000M9KFDE8.USD","LU0211328371.USD","LU2462157665.USD","LU2237443895.HKD","LU1035775433.USD","SG9999013999.USD","LU0949170772.SGD","LU0965509283.SGD","LU1003077747.HKD","LU0321505439.SGD","LU1983299246.USD","LU1066051225.USD","IE00BVYPNV92.GBP","SG9999014898.SGD","LU0345770993.USD","LU0210536198.USD","LU0672654240.SGD","IE00BVYPNW00.USD","LU2129689431.USD","LU0708995401.HKD","SG9999014906.USD","LU0985481810.HKD","BK4139","LU1232071149.USD","LU0310800379.SGD","LU0823416689.USD","LU1059921491.USD","LU0689472784.USD","SG9999003800.SGD","BK4550","LU0266013472.USD","IE0034235303.USD","LU2242652126.USD","GILD","IE00B7SZLL34.SGD","LU0310799852.SGD","LU1829250122.USD","LU1814569148.SGD","TAK","LU0289739343.SGD","IE00BN29S564.USD","LU0225283273.USD","BMY","SG9999001176.SGD","LU1585245621.USD","BK4532","LU0203201768.USD","LU0882574139.USD","LU1280957306.USD","IE00B1XK9C88.USD","LU0823434740.USD","LU1868836757.USD","LU2237443549.SGD","LU2471134952.CNY","LU0320765059.SGD","IE00BFSS8Q28.SGD","LU0861579265.USD","LU1718418525.SGD","IE00B3T34201.USD","LU2133065610.SGD","LU0094547139.USD","LU2211815571.USD","IE00BLSP4239.USD","LU0466842654.USD","LLY","SG9999015986.USD","LU2237443978.SGD","LU2468319806.SGD","LU2471134796.USD","LU1914381329.SGD","IE00BBT3K403.USD","IE00B42XCP33.USD","LU2236285917.USD","LU0203347892.USD","LU0354030438.USD","LU0661504455.SGD","IE00BJJMRY28.SGD","LU1066051811.HKD","LU2491050154.USD","LU0006306889.USD","LU2111349929.HKD","LU0029864427.USD","LU2746668974.SGD","LU1244550494.USD","BK4566","LU1989772840.SGD","LU0256863902.USD","LU1127390331.HKD","LU1868836914.USD","LU2129689514.USD","LU0868494617.USD","LU0823434583.USD","LU2129689605.HKD","LU2237438978.USD","IE00B7KXQ091.USD","LU2750360641.GBP","LU0471298694.HKD","LU1720051017.SGD","LU0943347566.SGD","SGXZ99366536.SGD","LU0070217475.USD","BK4588","LU0417517546.SGD","LU1064131342.USD","BK4578","BK4533","LU2237443465.HKD","LU2108987350.USD","LU2592432038.USD","LU0289739699.SGD","LU1291159041.SGD","BK4599","LU0234572021.USD","LU1674673428.USD","LU2417539215.USD","IE00B19Z3B42.SGD","IE0004445239.USD","IE00BK4W5M84.HKD","LU0553294199.USD","LU1196500208.SGD","LU2168563687.JPY","LU2552382058.USD","LU1894683348.USD","LU0070302665.USD","LU0511384066.AUD","LU0456855351.SGD","ABBV","LU1267930730.SGD","LU0345770308.USD","LU2361044865.SGD","LU2552382132.HKD","LU1868836591.USD","IE00BFTCPJ56.SGD","LU0170899867.USD","LU1057294990.SGD","LU2360106947.USD","LU1571399168.USD","IE00B19Z3581.USD","LU2271345857.HKD","LU2360032135.SGD","LU2361044949.HKD","LU1244550577.SGD","LU1670710661.SGD","LU0320765992.SGD","LU0795875169.SGD","LU0203345920.USD","LU0238689110.USD","BK4592","SG9999002232.USD","LU0965509101.SGD","LU0471298777.SGD","LU1732800096.USD","LU0058720904.USD","LU0708994859.HKD","IE00BLSP4452.SGD","LU0061475181.USD","LU0124676726.USD","LU1267930573.SGD","LU2237443622.USD","LU0795875086.SGD","LU1162221912.USD","LU2347655156.SGD","LU0786609619.USD","LU2602419157.SGD","BK4585","LU2023251221.USD","LU2361045086.USD","LU0097036916.USD","LU1323610961.USD","SG9999018857.SGD","LU0225284248.USD","LU1670711040.USD","LU2456880835.USD","LU1551013425.SGD","LU1623119135.USD","LU0267386448.USD","LU1974910355.USD","SGXZ31699556.SGD","LU2471134879.HKD","LU1868837300.USD","LU1366192091.USD","SG9999015945.SGD","LU1221951046.USD","LU1430594728.SGD","LU2089283258.USD","IE00BFSS7M15.SGD","LU0106261372.USD","SGXZ51526630.SGD","IE00BFXG1179.USD","LU0323591593.USD","IE0004445015.USD","LU1670710588.SGD","LU1674673691.USD","IE00BJJMRZ35.SGD","LU0057025933.USD","SG9999014880.SGD","LU0912757837.SGD","LU0320765646.SGD","LU2112291526.USD","SG9999001440.SGD","LU0820561909.HKD","LU0203202063.USD","LU2028103732.USD","LU0353189763.USD","LU0320765489.SGD","GSK","LU1267930490.SGD","LU0787776722.HKD","LU0306806265.USD","LU1989772923.USD","BK4568","LU1988902786.USD","LU2552382215.SGD","LU1221951129.SGD","LU2471134523.USD","LU2430703178.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU1868837136.USD","LU2357305700.SGD","LU1670711123.USD","IE00BJLML261.HKD","LU0472753341.HKD","LU1935042991.SGD","LU2168564149.EUR","LU1074936037.SGD","IE00BJT1NW94.SGD","LU1267930813.SGD","LU0211327993.USD","BK4534","LU2168564495.EUR","IE00B775H168.HKD","BK4583","LU2505996509.AUD","IE00BJJMRX11.SGD","LU2089984988.USD","LU2087621335.USD","SG9999018865.SGD","LU2491049909.HKD","LU0237698245.USD","IE00BN8TJ469.HKD","LU1732799900.SGD","BK4516","LU1839511570.USD","LU0820561818.USD","IE00B3PB1722.GBP","LU1061106388.HKD","LU2265009873.SGD","LU0385154629.USD","LU0345769128.USD","LU1066051498.USD","IE0005OL40V9.USD","NVS","LU0098860793.USD","LU1037948897.HKD","BK4007","LU1032466523.USD","LU1934455277.USD","LU0689626769.HKD","LU0109391861.USD","BK4559","LU2430703095.HKD","LU0096364046.USD","LU1261432733.SGD","LU1496350171.SGD","IE00BKVL7J92.USD","LU0985320562.USD","IE00BDGV0183.EUR","LU1548497426.USD","LU2125154935.USD","LU1244550221.USD","LU1883839398.USD","LU2491050071.SGD","SG9999002224.SGD","SG9999015978.USD","LU0198837287.USD","LU1066053197.SGD","LU2324357040.USD","IE00B2B36J28.USD","LU1804176565.USD","IE0002141913.USD","LU1496350502.SGD","LU0965509010.AUD","LU1023059063.AUD","RHHBY","LU2896262040.SGD","IE0009355771.USD","LU0079474960.USD","SGXZ81514606.USD","LU0122379950.USD","IE00BKDWB100.SGD","LU0345769631.USD","LU0432979614.USD","LU0738911758.USD","LU0792757196.USD","LU2089284900.SGD","LU0889566641.SGD","LU2237443382.USD","LU1929549753.HKD","LU1934455194.USD","GSK.UK","JNJ","LU2023250504.SGD","LU0256863811.USD","LU1720051108.HKD","LU0640476718.USD","LU2168564222.USD","LU2168564065.EUR","LU2505996681.GBP","UCB","LU2242646821.SGD","LU0211331839.USD","LU1093756168.USD","LU0225771236.USD","LU0289961442.SGD","LU1037948541.HKD","LU1032955483.USD","LU1917777945.USD","LU1989771016.USD","LU1712237335.SGD","SGXZ57979304.SGD","SG9999001176.USD","BK4581","LU0208291251.USD","LU0965508806.USD","LU0128525929.USD","IE00BGHQF631.EUR","LU0889565916.HKD"],"gpt_icon":1},{"id":"2606910792","title":"European Pharmaceutical Stocks Follow U.S. Peers Down -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2606910792","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606910792?lang=en_us&edition=fundamental","pubTime":"2026-01-28 18:17","pubTimestamp":1769595420,"startTime":"0","endTime":"0","summary":"Copyright (c) 2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154236417.USD","LU1093756168.USD","RHHBY","LU1093756325.SGD","NVO","IE00BZ1G4Q59.USD","GSK","IE00BKVL7J92.USD","BK4585","IE00BFXG1179.USD","BK4007","03165","BK4599","SDZNY","BAYRY","BK4532","BK4588"],"gpt_icon":1},{"id":"2606736796","title":"GSK’s Benlysta Real‑World Study Nears the Finish Line: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2606736796","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606736796?lang=en_us&edition=fundamental","pubTime":"2026-01-28 00:30","pubTimestamp":1769531412,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. Study OverviewGlaxoSmithKline (GSK) is running a post‑marketing study t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-benlysta-real‑world-study-nears-the-finish-line-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-benlysta-real‑world-study-nears-the-finish-line-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","GSK.UK","BK4007","BK4588","BK4585","ISBC","LU1829250122.USD","BK4532","BK4211"],"gpt_icon":0},{"id":"2606225201","title":"GlaxoSmithKline (GSK) Receives a New Rating from Bank of America Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2606225201","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606225201?lang=en_us&edition=fundamental","pubTime":"2026-01-27 16:25","pubTimestamp":1769502320,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Graham Parry initiated coverage with a Hold rating on GlaxoSmithKline today and set a price target of £19.00. Ac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-new-rating-from-bank-of-america-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-new-rating-from-bank-of-america-securities-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BAC","GSK"],"gpt_icon":0},{"id":"2606324789","title":"GSK Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2606324789","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606324789?lang=en_us&edition=fundamental","pubTime":"2026-01-27 01:07","pubTimestamp":1769447220,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.GSK PLC  shares rallied 1.53% to GBP18.29 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index  rising 0.05% to 10,148.85.GSK PLC closed 11.14% short of its 52-week high of GBP20.58, which the company reached on December 19th.Trading volume totaled 3.1 million, compared to the 50-day average of 8.0 million.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"gpt_icon":0},{"id":"2606244194","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2606244194","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606244194?lang=en_us&edition=fundamental","pubTime":"2026-01-27 00:06","pubTimestamp":1769443590,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week sharply higher late Monday morning, rising 1.21% to 1,812.72 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk  and software firm SAP , which rose 2.4% and 2.1%, respectively. They were followed by lender Banco Santander  and telecommunications company Ericsson , which were up 2% and 1.8%, respectively.The decliners from continental Europe were led by biopharmaceutical companies Cellectis  and DBV Technologies , which fell 6.4% and 3.1%, respectively. They were followed by semiconductor company Sequans Communications  and pharmaceutical company Ascendis Pharma , which were down 2.8% and 0.9%, respectively.From the UK and Ireland, the gainers were led by mining company BHP Group  and utilities company National Grid , which advanced 2.1% and 1.8%, respectively. They were followed by pharmaceutical company GSK  and lender Lloyds Banking ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4208","LU0300736062.USD","GSK.UK","BK4599","MREO","BK7507","BK7511","LU1093756168.USD","SAP","ASND","AMRN","BK4168","BK4141","BK4521","SQNS","BK4585","BK4588","BHP","BK4107","BK4505","BK4532","LU0320765992.SGD","ERIC","BK4020","BK4528","NGG","BK4613","BK4023","BK4117","BK4082","BK4591","AUTL","LU0889565916.HKD","LU1829250122.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","DBVT","BK7104","LYG","BK7095","LU0154236417.USD","BK4207","GSK","BK4554","LU0109394709.USD","BK4007","LU1093756325.SGD","BK4139","CLLS","NVO","BK4515","LU0300736492.USD","SAN","TRIB","BK7142"],"gpt_icon":1},{"id":"2605235195","title":"GSK Buyout Turns Volatile RAPT Into Food Allergy Cash-Out Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2605235195","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605235195?lang=en_us&edition=fundamental","pubTime":"2026-01-24 14:33","pubTimestamp":1769236409,"startTime":"0","endTime":"0","summary":"GSK has signed a definitive agreement to acquire RAPT Therapeutics (NasdaqGM:RAPT).\nThe deal centers on ozureprubart, a long acting anti-IgE antibody in Phase IIb trials for food allergy prophylaxis.\nThe transaction brings a food allergy candidate into GSK’s immunology and inflammation portfolio.\n\nRAPT Therapeutics, trading at $57.63, has recently seen very large 1 year returns and strong short term moves, with the share price up 64.2% over the past week and 60.8% over the past month. Year...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rapt/rapt-therapeutics/news/gsk-buyout-turns-volatile-rapt-into-food-allergy-cash-out-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rapt/rapt-therapeutics/news/gsk-buyout-turns-volatile-rapt-into-food-allergy-cash-out-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GSK","LU1829250122.USD","BK4139","BK4007","RAPT","BK4532","BK4588","BK4585","GSK.UK"],"gpt_icon":0},{"id":"2605471326","title":"GSK Says China Approves Trelegy Ellipta for Adults With Uncontrolled Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2605471326","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605471326?lang=en_us&edition=fundamental","pubTime":"2026-01-23 18:57","pubTimestamp":1769165847,"startTime":"0","endTime":"0","summary":"GSK  said Friday that China's National Medical Products Administration has approved Trelegy Ellipta for the treatment of adults with uncontrolled asthma, expanding the drug's use beyond its existing chronic obstructive pulmonary disease indication.The approval makes Trelegy the only single inhaler triple therapy approved in China for the maintenance treatment of both asthma and COPD, the company said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GSK.UK","GSK","BK4007","BK4532","LU1829250122.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2605419484","title":"GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2605419484","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605419484?lang=en_us&edition=fundamental","pubTime":"2026-01-23 02:17","pubTimestamp":1769105835,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Zain Ebrahim maintained a Sell rating on GlaxoSmithKline today and set a price target of £17.00. Ebrahim covers the Healthcare ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-j-p-morgan-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-gets-a-sell-from-j-p-morgan-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1720051017.SGD","LU1829250122.USD","LU1363072403.SGD","XLV","LU0158827948.USD","LU0006306889.USD","LU0225283273.USD","LU2089284900.SGD","XBI","BK4588","LABU","LU0795875169.SGD","BK4516","IE00BZ1G4Q59.USD","LU2271345857.HKD","LU1989772923.USD","BK4534","LU1720051108.HKD","LU1732800096.USD","LU0882574139.USD","LU0098860793.USD","BK4007","LU0528227936.USD","GSK","LU2089283258.USD","IE00BKVL7J92.USD","LU0234570918.USD","LU0912757837.SGD","LU2111349929.HKD","LU1074936037.SGD","LU1791710400.SGD","LU0106831901.USD","LU0267386448.USD","LU0158827781.USD","LU0557290698.USD","LU2357305700.SGD","LU2028103732.USD","LU1989772840.SGD","LU0971096721.USD","BK4504","BK4585","LU1244550221.USD","LU1244550577.SGD","LU1732799900.SGD","LU1548497426.USD","GSK.UK","LU2023251221.USD","LU1791710582.SGD","BK4127","LU0320765646.SGD"],"gpt_icon":0},{"id":"2605860415","title":"GSK Halts Early-Stage Sickle Cell Study, Tweaking the Risk Profile of Its Rare Disease Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2605860415","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605860415?lang=en_us&edition=fundamental","pubTime":"2026-01-23 00:30","pubTimestamp":1769099425,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK has updated the record for its Phase 1 study titled “A Randomized, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-halts-early-stage-sickle-cell-study-tweaking-the-risk-profile-of-its-rare-disease-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-halts-early-stage-sickle-cell-study-tweaking-the-risk-profile-of-its-rare-disease-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","GSK","LU1829250122.USD","SSI","BK4585","GSK.UK","BK4007","BK4588"],"gpt_icon":0},{"id":"1148106786","title":"Another \"Miracle Drug\" for Growth? Can \"Northeast Pharma Darling\" Replicate Its \"Hormone Legend\"?","url":"https://stock-news.laohu8.com/highlight/detail?id=1148106786","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148106786?lang=en_us&edition=fundamental","pubTime":"2026-01-22 17:32","pubTimestamp":1769074342,"startTime":"0","endTime":"0","summary":"A single ointment that has not yet entered clinical trials has managed to ignite the enthusiasm of investors. Since the beginning of the year, the stock price of \"Northeast Pharma Darling\" Changchun...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000661","BK0070","BK0239","BK0188","BK1161","LU1829250122.USD","BK1574","BK0075","BK0028","BK0042","688278","BK0060","GSK.UK","06978","BK4532","BK0046","BK0057","BK4007","GSK","BK4588","BK4585","300009"],"gpt_icon":0},{"id":"2605481882","title":"GSK and Alector Phase 3 Dementia Trial Ends Early: What Investors Need to Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2605481882","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605481882?lang=en_us&edition=fundamental","pubTime":"2026-01-22 00:30","pubTimestamp":1769013046,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK Update: Phase 3 Dementia Study With Alector Comes to an Early End S...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-and-alector-phase-3-dementia-trial-ends-early-what-investors-need-to-know?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-and-alector-phase-3-dementia-trial-ends-early-what-investors-need-to-know?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BK4585","BK4211","GSK.UK","BK4007","BK4588","BK4532","GSK","LU1829250122.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":0.0498},{"period":"1month","weight":0.0522},{"period":"3month","weight":0.1012},{"period":"6month","weight":0.3738},{"period":"1year","weight":0.4593},{"period":"ytd","weight":0.0522}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.0145},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1437},{"period":"ytd","weight":0.0147}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.013809},{"month":2,"riseRate":0.466667,"avgChangeRate":-0.001972},{"month":3,"riseRate":0.622222,"avgChangeRate":0.021018},{"month":4,"riseRate":0.673913,"avgChangeRate":0.032633},{"month":5,"riseRate":0.413043,"avgChangeRate":-0.008096},{"month":6,"riseRate":0.586957,"avgChangeRate":0.009648},{"month":7,"riseRate":0.543478,"avgChangeRate":0.003945},{"month":8,"riseRate":0.586957,"avgChangeRate":0.005806},{"month":9,"riseRate":0.521739,"avgChangeRate":0.005973},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}